---
figid: PMC9414690__membranes-12-00812-g001
figtitle: Interactions between the Nicotinic and Endocannabinoid Receptors at the
  Plasma Membrane
organisms:
- Mus musculus
- Rattus norvegicus
- Xenopus laevis
- Tetronarce californica
- Homo sapiens
- Cannabis sativa
organisms_ner:
- Mus musculus
- Homo sapiens
- Xenopus laevis
- Drosophila melanogaster
pmcid: PMC9414690
filename: membranes-12-00812-g001.jpg
figlink: /pmc/articles/PMC9414690/figure/membranes-12-00812-f001/
number: F1
caption: 'Schematic illustration of the biosynthetic pathway followed by ECs N-acylethanolamine
  (AN) and 2-arachidonoylglycerol (2-AG) by NAPE-PLD and DAG lipase, respectively.
  Both AN and 2-AG bind to presynaptic CB1Rs expressed on GABAergic, glutamatergic
  and cholinergic terminals, precluding neurotransmitter release. Induction of DOPA
  secretion by primary inhibition of GABA release is involved in the reward pathway
  in the brain. Abbreviations: PLD, N-acyl phosphatidylethanolamine phospholipase
  D; DAG, diacylglycerol; NAT, N-acyltransferase; PE, Phosphatidylethanolamine; nAChRs,
  nicotinic acetylcholine receptors; CB1R, cannabinoid type 1 receptor; AMPA, amino-3-hydroxy-5-methyl-4-isoazolepropionate
  receptor; GABA, γ-aminobutyric acid; GABAR, GABA receptor; NMDAR, N-methyl-D-aspartate
  receptor; DOPA, dopamine; DOPAR, DOPA receptor; VTA, ventral tegmental area; NAc,
  nucleus accumbens.'
papertitle: Interactions between the Nicotinic and Endocannabinoid Receptors at the
  Plasma Membrane.
reftext: Ana Sofía Vallés, et al. Membranes (Basel). 2022 Aug;12(8):812.
year: '2022'
doi: 10.3390/membranes12080812
journal_title: Membranes
journal_nlm_ta: Membranes (Basel)
publisher_name: MDPI
keywords: plasma membrane | membrane domains | nanodomains | neurotransmitter receptors
  | cannabinoids | acetylcholine receptor | cannabinoid receptor
automl_pathway: 0.9445841
figid_alias: PMC9414690__F1
figtype: Figure
redirect_from: /figures/PMC9414690__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9414690__membranes-12-00812-g001.html
  '@type': Dataset
  description: 'Schematic illustration of the biosynthetic pathway followed by ECs
    N-acylethanolamine (AN) and 2-arachidonoylglycerol (2-AG) by NAPE-PLD and DAG
    lipase, respectively. Both AN and 2-AG bind to presynaptic CB1Rs expressed on
    GABAergic, glutamatergic and cholinergic terminals, precluding neurotransmitter
    release. Induction of DOPA secretion by primary inhibition of GABA release is
    involved in the reward pathway in the brain. Abbreviations: PLD, N-acyl phosphatidylethanolamine
    phospholipase D; DAG, diacylglycerol; NAT, N-acyltransferase; PE, Phosphatidylethanolamine;
    nAChRs, nicotinic acetylcholine receptors; CB1R, cannabinoid type 1 receptor;
    AMPA, amino-3-hydroxy-5-methyl-4-isoazolepropionate receptor; GABA, γ-aminobutyric
    acid; GABAR, GABA receptor; NMDAR, N-methyl-D-aspartate receptor; DOPA, dopamine;
    DOPAR, DOPA receptor; VTA, ventral tegmental area; NAc, nucleus accumbens.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cnr1
  - Grin1
  - Brd2
  - Scn11a
  - Hspg2
  - Lipg
  - ci
  - Chrna7
  - Nlrp1a
  - CNR1
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - BRD2
  - AN
  - GPLD1
  - PLD1
  - PLD2
  - PLD3
  - PLD4
  - PLD5
  - PLD6
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - CHRNA4
  - XK
  - NLRP1
  - cnr1.S
  - cnr1.L
  - brd2.S
  - hspg2.L
  - chrna4.L
  - chrna4.S
  - pe
  - vta
  - Nmdar2
  - Nmdar1
  - na
  - an
  - Pld
  - norpA
  - sl
  - Plc21C
  - nAChRalpha3
  - nAChRalpha7
  - nAChRbeta3
  - nAChRalpha6
  - nAChRalpha5
  - nAChRbeta1
  - nAChRalpha4
  - nAChRalpha1
  - nAChRalpha2
  - nAChRbeta2
  - Rdl
  - GABA-B-R1
  - Gabat
  - nac
  - Nacalpha
---
